Inhibition of tumorigenicity in lung adenocarcinoma cells by c-erbB-2 antisense expression

Int J Cancer. 1997 Aug 7;72(4):631-6. doi: 10.1002/(sici)1097-0215(19970807)72:4<631::aid-ijc14>3.0.co;2-e.

Abstract

The lung carcinoma cell line Calu3, which overexpresses the c-erbB-2 oncogene, was stably transfected with antisense (AS) cDNA constructs encompassing different regions of the c-erbB-2 gene. Transfected cells were analyzed for their tumorigenic properties in vitro and in nude mice. Two independent clones, AS F1 (low erbB-2 expressor) and AS B12 (high erbB-2 expressor), as well as the polyclonal Calu3/AS 5', were selected for these analyses. In Calu3/AS 5' transfected cells and in the AS F1 clone, c-erbB-2 RNA and protein levels were lower than those detected in the parental cell line and the AS B12 clone. Anchorage-independent growth and tumor take were also significantly reduced. Furthermore, cells derived from primary tumors of Calu3/AS 5', AS F1 and AS B12 lost the AS c-erbB-2 DNA insert but retained the gene for G418 resistance. Our results suggest that a correlation between c-erbB-2 overexpression and tumorigenicity may exist in the Calu3 lung carcinoma cell line.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics
  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / therapy*
  • Animals
  • Base Sequence
  • Cell Division / drug effects
  • DNA, Complementary / genetics
  • Gene Expression
  • Genes, erbB-2*
  • Genetic Therapy / methods*
  • Humans
  • Lung Neoplasms / genetics
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / therapy*
  • Mice
  • Mice, Nude
  • Molecular Sequence Data
  • Oligonucleotides, Antisense / genetics
  • Oligonucleotides, Antisense / pharmacology*
  • Transfection
  • Tumor Cells, Cultured

Substances

  • DNA, Complementary
  • Oligonucleotides, Antisense

Associated data

  • GENBANK/M11730